Search Results

COVID-19 has brought an unexpected, unwelcome, and unwanted disruption to oncology care, as it has to every other facet of life. ACCC has met this unprecedented pandemic, however, with its characteristic “how to” approach.

Assuming the ACCC presidency in March of 2020, just as the COVID-19 public health emergency went into effect, was certainly a dramatic way to enter office. That said, I am pleased with how much we have accomplished these last 12 months— despite the nationwide shutdown and ongoing pandemic.

Oncology has always faced challenges, and cancer care teams are ever ready to change course and do what needs to be done to care for our patients and their families. But we do not have to do this alone. ACCC stands ready to assist.

As we turn the corner toward 2022, for oncology to drive equity forward: We need every member and every discipline, patient, leader, payer, industry partner, and innovator working together to provide the most equitable care possible in a sustainable way.

Despite the availability of vaccines, drugs, and monoclonal antibodies, the healthcare field is more challenged than ever with the Omicron variant.

This is my last column as Editor-in-Chief of Oncology Issues, and it has been a privilege to serve in this inaugural role.